Macrogenics reported $-66638000 in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Abbvie ABBV:US $ 5029M 601M
Amgen AMGN:US $ 2500M 196M
AstraZeneca AZN:LN 2.88B 1.57B
Biogen BIIB:US $ 531.5M 11.7M
Bristol Myers Squibb BMY:US $ 3188M 399M
Cerulean Pharma CERU:US $ -8400450 1.14M
Daiichi Sankyo 4568:JP -50747000000 89.78B
Eli Lilly And LLY:US $ 2569.9M 171.6M
Epizyme EPZM:US $ -50926000 360K
Genmab GEN:DC 514M 295M
Geron GERN:US $ -28675000 2.31M
Gilead Sciences GILD:US $ 2897M 1957M
Immunogen IMGN:US $ -22852000 11.7M
Johnson & Johnson JNJ:US $ 7540M 1623M
Karyopharm Therapeutics KPTI:US $ -34586000 81.55M
Macrogenics MGNX:US $ -66638000 8.4M
Merk MRK:US $ 5059M 207M
Mirati Therapeutics MRTX:US $ -184218000 12.86M
Pfizer PFE:US $ 9995M 4136M
Puma Biotechnology PBYI:US $ -747000 7.58M
Regeneron Pharmaceuticals REGN:US $ 1286.6M 1353.1M
Seattle Genetics SGEN:US $ -133050000 39.02M
Xencor XNCR:US $ 26.47M 65.19M